Related Experiment Video
Updated: Sep 18, 2025

Using Unidirectional Rotations to Improve Vestibular System Asymmetry in Patients with Vestibular Dysfunction
Published on: August 30, 2019
Sodium Channel Blockers for Vestibular Paroxysmia in Children
Pierre Reynard1,2, Hung Thai-Van1,2,3, Eugenia Mustea1
1Department of Audiology and Otoneurological Explorations, Civil Hospitals of Lyon, 69003 Lyon, France.
Vestibular paroxysmia (VP) in children is a treatable cause of vertigo. Sodium channel blockers like oxcarbazepine and carbamazepine show promising results, offering fast relief for pediatric patients.
Area of Science:
- Neurology
- Pediatrics
- Otolaryngology
Background:
- Vestibular paroxysmia (VP) is increasingly recognized in children, accounting for up to 4% of pediatric vertigo cases.
- A positive therapeutic response to sodium-channel-blocking drugs has been observed in pediatric VP.
Purpose of the Study:
- To review the current literature on vestibular paroxysmia in children.
- To provide guidance on the diagnosis and treatment of pediatric VP.
Main Methods:
- A comprehensive literature search was conducted using PubMed, Medline, Cochrane, and Crossref databases.
- Studies focusing on VP in children and the use of sodium channel blockers were selected for review.
Main Results:
- Limited evidence exists, with only five articles (case series/reports) identified.
- Oxcarbazepine (300-360 mg/day) and carbamazepine (50-200 mg/day) are the primary treatments, with efficacy reported within one week.
- Treatment duration typically spans six weeks.
Conclusions:
- Vestibular paroxysmia is a recognized condition in pediatric patients.
- Sodium channel blockers appear effective for pediatric VP, mirroring adult responses.
- Increased awareness is crucial for identifying this treatable cause of episodic vertigo in children.
More Related Videos
Related Concept Videos
Equilibrium and Balance
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
The Vestibular System

